Natus fleshes out neurology unit as slimming CareFusion offloads Nicolet
This article was originally published in Clinica
Executive Summary
CareFusion is selling its Nicolet neurodiagnostic business to Natus as part of its ongoing strategy to streamline its operations. The $58m all-cash deal will enable Natus to expand its existing neurology portfolio, while strengthening its presence outside the US.